Colgate-Palmolive Company vs Linde PLC — how do they compare? Colgate-Palmolive Company trades at $90.95 (market cap $74.59B), while Linde PLC trades at $520.27 (market cap $242.30B). The key difference: Linde PLC is far larger — about 3.2× Colgate-Palmolive Company's market cap, and Colgate-Palmolive Company pays the higher dividend (2.27%). Which is the better fit depends on your goals.
| CL | LIN | |
|---|---|---|
Market Cap | $74.59B | $242.30B |
Sector | Consumer Staples | Basic Materials |
52-Week High | $99.14 | $546.64 |
52-Week Low | $74.98 | $389.38 |
Enterprise Value | $81.22B | $264.66B |
Dividend Yield | 2.27% | 1.22% |
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
Linde (LIN) trades at $522.54, down 1.37% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $560. The company reported strong Q1 2026 EPS of $4.33, beating estimates, and maintains robust profitability with a net income margin of 20.44%. Recent news highlights sustainability leadership and strategic growth, though valuation ratios like a P/E of 34.75 suggest premium pricing.
The stock offers steady growth potential driven by earnings beats and dividend consistency, but faces risks from rising debt levels and macroeconomic pressures. Analyst sentiment is overwhelmingly bullish with 85.7% buy ratings, indicating confidence in Linde's operational strength and future performance, though investors should monitor debt trends and competitive dynamics.
Trailing returns across standard periods
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →